inositol has been researched along with Myocardial Ischemia in 5 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Reperfusion of ischemic rat hearts initiates the generation of inositol(1,4,5)trisphosphate [Ins(1,4,5)P3] and arrhythmias, provided that either norepinephrine or thrombin is present." | 3.69 | Ins(1,4,5)P3 and arrhythmogenic responses during myocardial reperfusion: evidence for receptor specificity. ( Dart, AM; Du, XJ; Jacobsen, AN; Woodcock, EA, 1997) |
| "In trimetazidine-treated cells, arachidonic acid incorporation was increased in the phospholipid, but not in other lipid fractions." | 1.30 | Is the cytoprotective effect of trimetazidine associated with lipid metabolism? ( Grynberg, A; Lucien, A; Sentex, E; Sergiel, JP, 1998) |
| "The inositol trisphosphate was higher in control than ischemic hearts (10 min, 30 min), 0." | 1.29 | A new method to measure cardiac inositol levels in intact animals. ( Antona, A; Bellanca, L; Bucca, V; D'Amico, C; Di Pasquale, P; Licata, G; Palazzoadriano, M; Paterna, S, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Omori, K | 1 |
| Katakami, N | 1 |
| Arakawa, S | 1 |
| Yamamoto, Y | 1 |
| Ninomiya, H | 1 |
| Takahara, M | 1 |
| Matsuoka, TA | 1 |
| Tsugawa, H | 1 |
| Furuno, M | 1 |
| Bamba, T | 1 |
| Fukusaki, E | 1 |
| Shimomura, I | 1 |
| Iwasa, M | 1 |
| Kobayashi, H | 1 |
| Yasuda, S | 1 |
| Kawamura, I | 1 |
| Sumi, S | 1 |
| Yamada, Y | 1 |
| Shiraki, T | 1 |
| Yamaki, T | 1 |
| Ushikoshi, H | 1 |
| Aoyama, T | 1 |
| Nishigaki, K | 1 |
| Takemura, G | 1 |
| Fujiwara, T | 1 |
| Fujiwara, H | 1 |
| Minatoguchi, S | 1 |
| Paterna, S | 1 |
| D'Amico, C | 1 |
| Di Pasquale, P | 1 |
| Antona, A | 1 |
| Bellanca, L | 1 |
| Bucca, V | 1 |
| Palazzoadriano, M | 1 |
| Licata, G | 1 |
| Jacobsen, AN | 1 |
| Du, XJ | 1 |
| Dart, AM | 1 |
| Woodcock, EA | 1 |
| Sentex, E | 1 |
| Sergiel, JP | 1 |
| Lucien, A | 1 |
| Grynberg, A | 1 |
5 other studies available for inositol and Myocardial Ischemia
| Article | Year |
|---|---|
Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS.
Topics: Aged; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickness; Coronary Artery Disease; Diabetes | 2020 |
Antidiabetic drug voglibose is protective against ischemia-reperfusion injury through glucagon-like peptide 1 receptors and the phosphoinositide 3-kinase-Akt-endothelial nitric oxide synthase pathway in rabbits.
Topics: alpha-Glucosidases; Animals; Arginine; Decanoic Acids; Glucagon-Like Peptide 1; Glucagon-Like Peptid | 2010 |
A new method to measure cardiac inositol levels in intact animals.
Topics: Animals; Blood Pressure; Cyclic AMP; Inositol; Male; Myocardial Ischemia; Myocardial Reperfusion; My | 1996 |
Ins(1,4,5)P3 and arrhythmogenic responses during myocardial reperfusion: evidence for receptor specificity.
Topics: Animals; Arrhythmias, Cardiac; Endothelin-1; Endothelin-3; Heart Rate; In Vitro Techniques; Inositol | 1997 |
Is the cytoprotective effect of trimetazidine associated with lipid metabolism?
Topics: Animals; Cells, Cultured; Choline; Chromatography, Gas; Ethanolamine; Fatty Acids; Inositol; Linolei | 1998 |